Premature ovarian failure;L'insuffisance ovarienne prématurée

Annales d'Endocrinologie

Volumn 67, Issue 6, 2006, Pages 557-566

  Christin Maitre, S ^a   Pasquier, M ^a   Donadille, B ^a   Bouchard, P ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

FMR1; Ovary; Premature ovarian failure; X chromosome

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; GONADOTROPIN; GROWTH DIFFERENTIATION FACTOR 9; STEROID 17ALPHA MONOOXYGENASE;

AMENORRHEA; AUTOIMMUNITY; CARDIOVASCULAR RISK; CHEMOTHERAPY; CONCEPTION; FERTILITY; FOXL2 GENE; FRAXA GENE; GENE; GENETICS; HORMONE SUBSTITUTION; HUMAN; IATROGENIC DISEASE; INFERTILITY; INTESTINE LYMPHATIC TISSUE; OOCYTE DONATION; OSTEOPOROSIS; PREMATURE OVARIAN FAILURE; REVIEW; RFSH GENE; TURNER SYNDROME; VIROLOGY;

EID: 33845962386     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(06)73007-4     Document Type: Review

References (80)

1. Abdalla HI, Baber RJ, Kirkland A, Leonard T, Studd JW. Pregnancy in women with premature ovarian failure using tubal and intrauterine transfer of cryopreserved zygotes. Br J Obstet Gynaecol 1989 ; 96 : 1071-5.
2. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990 ; 322 : 1829-36.
3. Aittomaki K, Herva R, Stenman UH, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996 ; 81 : 3722-6.
4. Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995 ; 82 : 959-68.
5. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 1999 ; 83 : 322-5.
6. Amati P, Gasparini P, Zlotogora J, et al. A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23. Am J Hum Genet 1996 ; 58 : 1089-92.
7. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998 ; 91 : 12-5.
8. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, et al. A novel phenotype related to partial loss of function mutations of the FSH receptor. J Clin Invest 1998 ; 102 : 1352-9.
9. Berger K, Souza H, Brito VN, d'Alva CB, Mendonca BB, Latronico AC. Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes. Fertil Steril 2005 ; 83 : 466-70.
10. Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998 ; 62 : 533-41.
11. Bose HS, Sugawara T, Strauss JF, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 1996 ; 335 : 1870-8
12. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998 ; 13 : 1184-7.
13. Conway GS. Premature ovarian failure. Br Med Bull 2000 ; 56 : 643-9.
14. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986 ; 67 : 604-6.
15. Cramer DW, Xu H. Predicting age at menopause. Maturitas 1996 ; 23 : 319-26.
16. Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril 1995 ; 64 : 740-5.
17. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001 ; 27 : 159-66.
18. de Baere E, Copelli S, Caburet S, Laissue P, Beysen D et al. Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis- epicantus inversus syndrome and ovarian dysfunction. Pediatr Endocrinol Rev 2005 ; 2 : 653-60.
19. de Bruin JP, Bovenhuis H, Van Noord PA et al. The role of genetic factors in age at natural menopause. Hum Reprod 2001 ; 16 : 2014-8.
20. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004 ; 75 : 106-11.
21. di Pasquale Rossetti R, Marozzi A et al. Identification of new variants of human BMP15 in a large cohort with premature ovarian failure. J Clin Endocrinol Metab 2006 ; 91 : 1976-9.
22. Dixit H, Rao LK, Padmalatha V, et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 2005 ; 12 : 749-54.
23. Donnez J, Dolmans MM. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004 : 364 : 2092-3.
24. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 1998 ; 12 : 1809-17.
25. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992 ; 7 : 1342-6.
26. Fenichel P. Prevalence, specificity, significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 1997 ; 12 : 2623-28.
27. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P. Pathophysiology of impaired ovarian function in galactosemia. Hum Reprod Update 2006 ; 12 : 573-84.
28. Franchi-Razgui P, Rousselot P, Espie M et al. Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 2003 ; 4 : 116-20.
29. Galloway SM, Mcnatty KP, Cambridge LM et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000 ; 25 : 279-83.
30. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005 ; 11 : 391-410.
31. Groff AA, Covington SN, Halverson LR et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005 ; 83 : 1734-41.
32. Harris SE, Chand AL, Winship IM et al. INHA promoter polymorphisms are associated with premature ovarian failure. Mol Hum Reprod 2005 ; 11 : 779-84.
33. Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med 2005 ; 118 : 131-5.
34. Huhtaniemi IT, Themmen AP. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 2005 ; 26 : 207-17.
35. Jacobs PA, Baikie AG, Brown WM, Macgregor TN, Maclean N, Harnden DG. Evidence for the existence of the human "super female". Lancet 1959 ; 2 : 423-5.
36. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004 ; 428 : 145-50.
37. Kalantaridou SN, Calis KA, Mazer NA, Godoy H, Nelson LM. A pilot study of an investigational testosterone transdermal patch system in young women with spontaneous premature ovarian failure. J Clin Endocrinol Metab 2005 ; 90 : 6549-52.
38. Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am 1998 ; 27 : 989-1006.
39. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.Trends Endocrinol Metab 2006 ; 17 : 101-9.
40. Van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999 ; 5 : 483-92.
41. Kok HS, Van Asselt KM, Van Der Schouw YT, Peeters PH, Wijmenga C. Genetic studies to identify genes underlying menopausal age. Hum Reprod Update 2005 ; 11 : 483-93.
42. Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 1988 ; 72 : 926-8.
43. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F et al. mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006 ; 154 : 1-6.
44. Letur H, Martin-Pont B, Fenichel P, GEDO. Spontaneous pregnancy and premature menopause. Gynecol Obstet Fertil 2004 ; 32 : 748-55.
45. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a muti-ethnic population study of the menopause transition. Hum Reprod 2003 ; 18 : 199-206.
46. Luoh SW, Bain PA, Polakiewicz RD, et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997 ; 124 : 2275-84.
47. Maraschio P, Tupler R, Barbierato L, et al. An analysis of Xq deletions. Hum Genet 1996 ; 97 : 375-81.
48. Matikainen TM, Moriyama T, Morita Y et al. Ligand activation of the aromatic hydrocarbon receptor transcription factor drives Bax-dependent apoptosis in developing fetal ovarian germ cells. Endocrinology 2002 ; 143 : 615-20.
49. Mckinlay SM. The normal menopause transition: an overview. Maturitas 1996 ; 23 : 137-45.
50. Meduri G, Touraine P, Beau I et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 2003 ; 88 : 3491-8.
51. Meyers CM, Boughman JA, Rivas M, Wilroy RS, Simpson JL. Gonadal (ovarian) dysgenesis in 46, XX individuals: frequency of the autosomal recessive form. Am J Med Genet 1996 ; 63 : 518-24.
52. Morishima A, Grumbach MM, Simpson ER, Fisher C, QIN K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995 ; 80 : 3689-98.
53. Murray A, Webb J, Dennis N, Conway G, Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 1999 ; 36 : 767-70.
54. Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998 ; 35 : 637-40.
55. Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nat Genet 1997 ; 17 : 393-8.
56. Oktay K, Tilly J. Livebirth after orthotopic transplantation of ovarian tissue. Lancet 2004 ; 364 : 2091-2.
57. Powell CM, Taggart RT, Drumheller TC et al. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994 ; 52 : 19-26.
58. Progetto Menopausa Italia Study Group Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. B J Obstet Gynecol 2003 ; 110 : 59-63.
59. Prueitt RL, Ross JL, Zinn AR. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 2000 ; 89 : 44-50.
60. Rappold GA, Henke A, Pohlschmid M, Huisman TH. Pseudoautosomal repeat displays higher variability in blacks than in Caucasians. Hum Genet 1992 ; 88 : 573-8.
61. Rizzolio F, Bione S, Sala C et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod 2006 ; 21 : 1477-83.
62. Rooman RP, Van Driessche K, Du Caju MV. Growth and ovarian function in girls with 48, XXXX karyotype - patient report and review of the literature. J Pediatr Endocrinol Metab 2002 ; 15 : 1051-5.
63. Sala C, Arrigo G, Torri G et al. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics 1997 ; 40 : 123-31.
64. Shelling AN, Burton KA, Chand AL et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000 ; 15 : 2644-9.
65. Siegel-Itzkovich J. Woman gives birth after receiving transplant of her own ovarian tissue. BMJ 2005 ; 331 : 70.
66. Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999 ; 89 : 186-200.
67. Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966 ; 155 : 369-83.
68. Snieder H, Mac Gregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998 ; 83 : 1875-80.
69. Sundblad V, Chiauzzi VA, Andreone L, Campo S, Charreau EH, Dain L. Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure. Hum Reprod 2006 ; 21 : 1154-60.
70. Sutherland GR, Baker E. Characterisation of a new rare fragile site easily confused with the fragile X. Hum Mol Genet 1992 ; 1 : 111-3.
71. Sybert VP, Mccauley E. Turner's syndrome. N Engl J Med 2004 ; 351 : 1227-38.
72. Tharapel AT, Anderson KP, Simpson JL et al. Deletion (X) (q26.1→q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am J Hum Genet 1993 ; 52 : 463-71.
73. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet 1990 ; 85 : 455-61.
74. Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood Bone Marrow Transplant 1998 ; 21 : 287-90.
75. Touraine P, Beau I, Gougeon A, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 1999 ; 13 : 1844-54.
76. Treloar SA, Do KA, Martin NG. Genetic influences on the age at menopause. Lancet 1998 ; 352 : 1084-5.
77. Uygur D, Sengul O, Bayar D, Erdinc S, Batioglu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 2005 ; 273 : 17-9.
78. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990 ; 13 : 802-18.
79. Wood C. Mumps and the menopause. Br J Sex Med 1975 ; 2 : 19.
80. Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998 ; 8 : 322-7.